YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, an… Read more
YungShin Global Holding Corp (3705) - Net Assets
Latest net assets as of September 2025: NT$8.58 Billion TWD
Based on the latest financial reports, YungShin Global Holding Corp (3705) has net assets worth NT$8.58 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$11.97 Billion) and total liabilities (NT$3.39 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$8.58 Billion |
| % of Total Assets | 71.65% |
| Annual Growth Rate | 3.19% |
| 5-Year Change | 51.7% |
| 10-Year Change | 61.96% |
| Growth Volatility | 5.64 |
YungShin Global Holding Corp - Net Assets Trend (2000–2024)
This chart illustrates how YungShin Global Holding Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for YungShin Global Holding Corp (2000–2024)
The table below shows the annual net assets of YungShin Global Holding Corp from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$9.98 Billion | +26.04% |
| 2023-12-31 | NT$7.91 Billion | +2.75% |
| 2022-12-31 | NT$7.70 Billion | +13.48% |
| 2021-12-31 | NT$6.79 Billion | +3.22% |
| 2020-12-31 | NT$6.58 Billion | +2.45% |
| 2019-12-31 | NT$6.42 Billion | +3.54% |
| 2018-12-31 | NT$6.20 Billion | +2.93% |
| 2017-12-31 | NT$6.02 Billion | +0.11% |
| 2016-12-31 | NT$6.02 Billion | -2.33% |
| 2015-12-31 | NT$6.16 Billion | +4.48% |
| 2014-12-31 | NT$5.90 Billion | +4.48% |
| 2013-12-31 | NT$5.64 Billion | +0.75% |
| 2012-12-31 | NT$5.60 Billion | -2.06% |
| 2011-12-31 | NT$5.72 Billion | +2.69% |
| 2010-12-31 | NT$5.57 Billion | +3.34% |
| 2009-12-31 | NT$5.39 Billion | +1.01% |
| 2008-12-31 | NT$5.34 Billion | +1.12% |
| 2007-12-31 | NT$5.28 Billion | +4.34% |
| 2006-12-31 | NT$5.06 Billion | +1.00% |
| 2005-12-31 | NT$5.01 Billion | 0.00% |
| 2004-12-31 | NT$5.01 Billion | +4.71% |
| 2003-12-31 | NT$4.78 Billion | +2.77% |
| 2002-12-31 | NT$4.65 Billion | -1.84% |
| 2001-12-31 | NT$4.74 Billion | +0.92% |
| 2000-12-31 | NT$4.70 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to YungShin Global Holding Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 73.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$1.94 Billion | 24.35% |
| Common Stock | NT$2.66 Billion | 33.43% |
| Other Comprehensive Income | NT$1.03 Billion | 12.93% |
| Other Components | NT$2.33 Billion | 29.29% |
| Total Equity | NT$7.97 Billion | 100.00% |
YungShin Global Holding Corp Competitors by Market Cap
The table below lists competitors of YungShin Global Holding Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bajaj Consumer Care Limited
NSE:BAJAJCON
|
$292.15 Million |
|
Paslin Digital Technology Co Ltd
SHG:600215
|
$292.27 Million |
|
Huarui Electrical Appliance Co Ltd
SHE:300626
|
$292.29 Million |
|
Dabaco
VN:DBC
|
$292.30 Million |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
$292.08 Million |
|
Guangzhou Frontop Digital Creative Technology Co. Ltd. A
SHE:301313
|
$291.93 Million |
|
Argosy Research
TWO:3217
|
$291.91 Million |
|
BayCom Corp
NASDAQ:BCML
|
$291.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in YungShin Global Holding Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,342,674,000 to 7,969,631,000, a change of 626,957,000 (8.5%).
- Net income of 1,168,508,000 contributed positively to equity growth.
- Dividend payments of 672,883,000 reduced retained earnings.
- Other comprehensive income increased equity by 186,001,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$1.17 Billion | +14.66% |
| Dividends Paid | NT$672.88 Million | -8.44% |
| Other Comprehensive Income | NT$186.00 Million | +2.33% |
| Other Changes | NT$-54.67 Million | -0.69% |
| Total Change | NT$- | 8.54% |
Book Value vs Market Value Analysis
This analysis compares YungShin Global Holding Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.77x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.81x to 1.77x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | NT$18.82 | NT$52.90 | x |
| 2006-12-31 | NT$18.98 | NT$52.90 | x |
| 2008-12-31 | NT$19.56 | NT$52.90 | x |
| 2009-12-31 | NT$19.61 | NT$52.90 | x |
| 2010-12-31 | NT$20.29 | NT$52.90 | x |
| 2011-12-31 | NT$20.82 | NT$52.90 | x |
| 2012-12-31 | NT$20.44 | NT$52.90 | x |
| 2013-12-31 | NT$20.47 | NT$52.90 | x |
| 2014-12-31 | NT$21.36 | NT$52.90 | x |
| 2015-12-31 | NT$22.29 | NT$52.90 | x |
| 2016-12-31 | NT$21.85 | NT$52.90 | x |
| 2017-12-31 | NT$22.08 | NT$52.90 | x |
| 2018-12-31 | NT$22.83 | NT$52.90 | x |
| 2019-12-31 | NT$23.46 | NT$52.90 | x |
| 2020-12-31 | NT$24.03 | NT$52.90 | x |
| 2021-12-31 | NT$24.54 | NT$52.90 | x |
| 2022-12-31 | NT$26.87 | NT$52.90 | x |
| 2023-12-31 | NT$27.56 | NT$52.90 | x |
| 2024-12-31 | NT$29.91 | NT$52.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently YungShin Global Holding Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.66%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.55%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 1.73x
- Recent ROE (14.66%) is above the historical average (10.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 6.36% | 10.36% | 0.51x | 1.21x | NT$-166.73 Million |
| 2001 | 8.32% | 12.18% | 0.50x | 1.36x | NT$-77.11 Million |
| 2002 | 9.73% | 14.25% | 0.50x | 1.37x | NT$-12.77 Million |
| 2003 | 10.45% | 15.62% | 0.49x | 1.37x | NT$21.53 Million |
| 2004 | 14.43% | 18.73% | 0.56x | 1.38x | NT$221.56 Million |
| 2005 | 14.43% | 25.71% | 0.48x | 1.16x | NT$221.56 Million |
| 2006 | 9.31% | 15.89% | 0.51x | 1.15x | NT$-35.02 Million |
| 2007 | 10.81% | 14.94% | 0.56x | 1.29x | NT$41.93 Million |
| 2008 | 2.29% | 12.72% | 0.15x | 1.23x | NT$-403.16 Million |
| 2009 | 10.04% | 12.85% | 0.61x | 1.27x | NT$1.97 Million |
| 2010 | 11.75% | 15.33% | 0.60x | 1.28x | NT$94.48 Million |
| 2011 | 9.99% | 12.31% | 0.62x | 1.32x | NT$-476.70K |
| 2012 | 8.16% | 9.45% | 0.64x | 1.36x | NT$-100.10 Million |
| 2013 | 11.35% | 12.23% | 0.62x | 1.51x | NT$73.55 Million |
| 2014 | 12.65% | 12.36% | 0.67x | 1.53x | NT$151.03 Million |
| 2015 | 15.04% | 14.80% | 0.65x | 1.56x | NT$299.34 Million |
| 2016 | 11.31% | 10.63% | 0.61x | 1.75x | NT$75.96 Million |
| 2017 | 8.74% | 7.76% | 0.60x | 1.87x | NT$-74.19 Million |
| 2018 | 11.54% | 9.34% | 0.64x | 1.93x | NT$93.61 Million |
| 2019 | 11.98% | 9.14% | 0.66x | 1.98x | NT$123.59 Million |
| 2020 | 12.36% | 9.79% | 0.64x | 1.97x | NT$151.39 Million |
| 2021 | 11.27% | 9.44% | 0.65x | 1.84x | NT$82.83 Million |
| 2022 | 11.72% | 11.48% | 0.62x | 1.66x | NT$123.05 Million |
| 2023 | 11.27% | 11.77% | 0.61x | 1.57x | NT$93.04 Million |
| 2024 | 14.66% | 14.55% | 0.58x | 1.73x | NT$371.54 Million |
Industry Comparison
This section compares YungShin Global Holding Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $4,509,803,556
- Average return on equity (ROE) among peers: 3.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| YungShin Global Holding Corp (3705) | NT$8.58 Billion | 6.36% | 0.40x | $292.12 Million |
| Grape King Bio Ltd (1707) | $11.79 Billion | 12.28% | 0.30x | $413.97 Million |
| Standard Chemical & Pharmaceutical Co Ltd (1720) | $8.14 Billion | 10.26% | 0.37x | $160.24 Million |
| Maywufa Co Ltd (1731) | $2.11 Billion | 8.22% | 0.51x | $41.33 Million |
| Allied Biotech Corporation (1780) | $1.17 Billion | 8.33% | 0.78x | $47.92 Million |
| ScinoPharm Taiwan Ltd (1789) | $9.38 Billion | 5.16% | 0.21x | $180.77 Million |
| GeneFerm Biotechnology Co Ltd (1796) | $396.19 Million | 1.14% | 1.48x | $24.30 Million |
| Easywell Biomedicals Inc. (1799) | $696.90 Million | -39.00% | 0.68x | $62.14 Million |
| LIWANLI Innovation Co Ltd (3054) | $799.59 Million | 4.48% | 0.55x | $49.55 Million |
| TTY Biopharm Co Ltd (4105) | $6.11 Billion | 22.00% | 0.56x | $486.74 Million |